MedPath

Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia

Not Applicable
Completed
Conditions
Insomnia
Registration Number
NCT06021795
Lead Sponsor
Third Wave Therapeutics
Brief Summary

Assess the effect of a customized audio track delivered via standard commercially-available bone conduction headsets on the quality of sleep

Detailed Description

A single-center study in 25 subjects suffering from moderate to severe insomnia and assess the effectiveness of the intervention. Intervention consists of treatment using a customized audio track delivered via standard commercially-available bone conduction headsets daily for four (4) weeks. Effectiveness is defined by a statistically significant improvement in Insomnia Severity Index (ISI) and Pittsburgh Sleep Quality Index (PSQI) at baseline versus the end of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • 18 years of age and older
  • Meets DSM 5 criteria for insomnia disorder
  • Insomnia Severity Index (ISI) of 15 - 28
Exclusion Criteria
  • Use of sleep medications, sedating or alerting medications or antidepressants in the last 3 months
  • Diagnosis of any autoimmune disorder or any medical or sleep disorder that could affect sleep
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Insomnia Severity Index (ISI)4 weeks

Reduction in Insomnia Severity

Secondary Outcome Measures
NameTimeMethod
Change in Pittsburgh Sleep Quality Index (PSQI)4 weeks

Reduction in Sleep Quality

Trial Locations

Locations (1)

San Francisco Otolaryngology Medical Group

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

San Francisco Otolaryngology Medical Group
πŸ‡ΊπŸ‡ΈSan Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.